Cnb Bank Abbott Laboratories Transaction History

Cnb Bank

$195 Million
Q1 2025

A detailed history of Cnb Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Cnb Bank holds 6,324 shares of ABT stock, worth $861,708. This represents 0.43% of its overall portfolio holdings.

Number of Shares

6,324

Previous 6,414 1.4%

Holding current value

$861,708

Previous $725,000 15.59%

% of portfolio

0.43%

Previous 0.34%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 24, 2025	SELL	$111.1 - $140.22 $9,999 - $12,619	-90 Reduced 1.4%	6,324 $838,000
Q4 2024 Jan 15, 2025	SELL	$111.93 - $119.39 $66,486 - $70,917	-594 Reduced 8.48%	6,414 $725,000
Q3 2024 Oct 18, 2024	SELL	$100.07 - $118.13 $33,023 - $38,982	-330 Reduced 4.5%	7,008 $798,000
Q2 2024 Aug 08, 2024	SELL	$100.73 - $112.44 $19,340 - $21,588	-192 Reduced 2.55%	7,338 $762,000
Q1 2024 May 02, 2024	SELL	$109.52 - $120.96 $11,280 - $12,458	-103 Reduced 1.35%	7,530 $855,000
Q4 2023 Jan 31, 2024	SELL	$90.19 - $110.4 $29,852 - $36,542	-331 Reduced 4.16%	7,633 $840,000
Q3 2023 Nov 02, 2023	BUY	$95.53 - $114.62 $40,313 - $48,369	422 Added 5.6%	7,964 $771,000
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $11,892 - $13,250	-118 Reduced 1.54%	7,542 $822,000
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $9,589 - $11,286	-99 Reduced 1.28%	7,660 $775,000
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $9,696 - $11,375	-102 Reduced 1.3%	7,759 $852,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $10,450 - $12,099	-108 Reduced 1.36%	7,861 $761,000
Q2 2022 Aug 19, 2022	SELL	$102.07 - $123.37 $33,683 - $40,712	-330 Reduced 3.98%	7,969 $866,000
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $20,209 - $24,427	198 Added 2.44%	8,299 $902,000
Q1 2022 Apr 13, 2022	SELL	$114.02 - $139.04 $35,688 - $43,519	-313 Reduced 3.72%	8,101 $959,000
Q4 2021 Jan 31, 2022	SELL	$115.53 - $141.46 $14,094 - $17,258	-122 Reduced 1.43%	8,414 $1.18 Million
Q3 2021 Nov 02, 2021	SELL	$116.66 - $129.06 $47,597 - $52,656	-408 Reduced 4.56%	8,536 $1.01 Million
Q2 2021 Jul 29, 2021	BUY	$105.79 - $124.53 $6,558 - $7,720	62 Added 0.7%	8,944 $1.04 Million
Q1 2021 May 03, 2021	BUY	$108.84 - $128.23 $28,189 - $33,211	259 Added 3.0%	8,882 $1.06 Million
Q4 2020 Jan 27, 2021	BUY	$105.0 - $114.42 $840 - $915	8 Added 0.09%	8,623 $944,000
Q3 2020 Oct 26, 2020	SELL	$91.64 - $111.29 $171,550 - $208,334	-1,872 Reduced 17.85%	8,615 $938,000
Q2 2020 Jul 14, 2020	SELL	$76.57 - $98.0 $50,383 - $64,484	-658 Reduced 5.9%	10,487 $959,000
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $92,219 - $134,850	-1,468 Reduced 11.64%	11,145 $879,000
Q4 2019 Jan 27, 2020	SELL	$78.51 - $87.4 $21,040 - $23,423	-268 Reduced 2.08%	12,613 $1.1 Million
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $241,755 - $262,137	-2,954 Reduced 18.65%	12,881 $1.08 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $92,193 - $107,525	-1,265 Reduced 7.4%	15,835 $1.33 Million
Q1 2019 Apr 29, 2019	BUY	$66.22 - $80.06 $208,460 - $252,028	3,148 Added 22.56%	17,100 $1.37 Million
Q4 2018 Feb 06, 2019	BUY	$65.56 - $74.27 $108,960 - $123,436	1,662 Added 13.52%	13,952 $1.01 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $3,770 - $4,548	62 Added 0.51%	12,290 $901,000
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $38,514 - $42,508	669 Added 5.79%	12,228 $745,000
Q1 2018 May 11, 2018	BUY	$56.27 - $63.62 $149,396 - $168,911	2,655 Added 29.82%	11,559 $693,000
Q4 2017 Feb 20, 2018	BUY	$53.68 - $57.47 $477,966 - $511,712	8,904	8,904 $508,000

Others Institutions Holding ABT

# of Institutions

3,546

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $239B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cnb Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cnb Bank with notifications on news.

Account